LON:SBS Source BioScience (SBS) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Source BioScience Stock (LON:SBS) 30 days 90 days 365 days Advanced Chart Get Source BioScience alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume458,233 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Source BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation. Read More Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Source BioScience and its competitors with MarketBeat's FREE daily newsletter. Email Address SBS Stock News HeadlinesSource BioScience enhances clinical diagnostics portfolio with CCL acquisitionApril 11, 2025 | msn.comSource Bioscience acquires Cambridge Clinical LaboratoriesApril 10, 2025 | msn.comPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.July 4 at 2:00 AM | Crypto Swap Profits (Ad)Source Agriculture Corp. Makes Strategic Investment in Ascribe Bioscience to Advance Sustainable Crop Protection SolutionsNovember 27, 2024 | tmcnet.comSkye Bioscience Shares Gain After Highlighting Safety of In-Development Obesity TreatmentSeptember 24, 2024 | marketwatch.comSerán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial FacilitySeptember 17, 2024 | tmcnet.comWhat are reliable sources?August 28, 2024 | bbc.co.ukAI platform for vegetable growers named AgTech Startup of the YearAugust 22, 2024 | msn.comSee More Headlines SBS Stock Analysis - Frequently Asked Questions How do I buy shares of Source BioScience? Shares of SBS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Source BioScience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Source BioScience investors own include Anglo American (AAL), Hastings Group Holdings plc (HSTG.L) (HSTG), Renishaw (RSW), Spirent Communications (SPT), Rotork (ROR), Hiscox (HSX) and Anglo American (NGLOY). Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryUtilities Current SymbolLON:SBS CIKN/A Webwww.sabesp.com.br Phone+44-115-9739012FaxN/AEmployees12,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (LON:SBS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Source BioScience plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Source BioScience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.